chr8-101558583-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_024915.4(GRHL2):​c.449T>G​(p.Ile150Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

GRHL2
NM_024915.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.10

Publications

0 publications found
Variant links:
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 28
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: STRONG Submitted by: ClinGen
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
  • nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital fibrosis of extraocular muscles
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13626263).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL2NM_024915.4 linkc.449T>G p.Ile150Ser missense_variant Exon 4 of 16 ENST00000646743.1 NP_079191.2 Q6ISB3-1
GRHL2NM_001330593.2 linkc.401T>G p.Ile134Ser missense_variant Exon 4 of 16 NP_001317522.1 Q6ISB3-2B4DL28
GRHL2NM_001440448.1 linkc.401T>G p.Ile134Ser missense_variant Exon 4 of 16 NP_001427377.1
GRHL2NM_001440447.1 linkc.449T>G p.Ile150Ser missense_variant Exon 4 of 16 NP_001427376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL2ENST00000646743.1 linkc.449T>G p.Ile150Ser missense_variant Exon 4 of 16 NM_024915.4 ENSP00000495564.1 Q6ISB3-1
GRHL2ENST00000395927.1 linkc.401T>G p.Ile134Ser missense_variant Exon 4 of 16 2 ENSP00000379260.1 Q6ISB3-2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 10, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Ile150Ser variant in GRHL2 has not been previously reported in individuals w ith hearing loss or in large population studies. Computational analyses (biochem ical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, add itional information is needed to determine the clinical significance of this var iant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
19
DANN
Uncertain
0.97
DEOGEN2
Benign
0.053
T;T;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.79
.;T;T
M_CAP
Benign
0.0055
T
MetaRNN
Benign
0.14
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
3.1
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.39
N;.;N
REVEL
Benign
0.10
Sift
Benign
0.24
T;.;T
Sift4G
Benign
0.31
T;.;T
Polyphen
0.0010
B;B;.
Vest4
0.52
MutPred
0.51
Gain of disorder (P = 0.0019);Gain of disorder (P = 0.0019);.;
MVP
0.043
MPC
0.53
ClinPred
0.31
T
GERP RS
4.6
Varity_R
0.10
gMVP
0.38
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727504883; hg19: chr8-102570811; API